This Blockbuster Drug from AbbVie Is Closer to Another Major Indication

This Blockbuster Drug from AbbVie Is Closer to Another Major Indication

Submitted by admin on July 5, 2022 - 11:05am
Source: 
Motley Fool
News Tags: 
Rinvoq
AbbVie
Europe
ulcerative colitis
Headline: 
This Blockbuster Drug from AbbVie Is Closer to Another Major Indication
snippet: 
  • Rinvoq could soon gain access to a market of hundreds of thousands of potential patients.
  • The indication could generate $300 million in annual sales for AbbVie.
  • AbbVie's stock seems like a buy for investors looking for steadily growing income.

Do Not Allow Advertisers to Use My Personal information